Komori
Gmo Prime Strategy (5250) · InitiativeAchieved

Stock Listings and Raising Growth Capital through Public Offerings and Third-Party Allotments

First written in FY2022. 1 of 3 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2023.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2023-Q1 – FY20232023: 220232024: 12024
Same theme, other companies
Multipurpose Fundraising through a Public Offering and Private Placement in Connection with a ListingA theme 42 companies write about · 0 as a headwind · 42 as a tailwind

2 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 42 companies compared. The sentences above are computed from all 42.
Full recordFilings, disclosures and news, newest first
  1. FY2023AchievedAnnual report

    「Because the Company listed its shares on the Tokyo Stock Exchange Standard Market on 22 February 2023, diluted net income per share for the fiscal year was calculated by treating the average share price from the listing date through the end of the fiscal year as the average share price during the period. Cash flows from financing activities 630,179 This was mainly attributable to ¥778.789 million in proceeds from the issuance of shares, among other items.」

    The listing on the Tokyo Stock Exchange Standard Market, the public offering and the third-party allotment were completed, and the fiscal year included ¥778.789 million in proceeds from the issuance of shares.
  2. FY2023-Q1AdvancedAnnual report

    「The total number of shares issued increased by 145,000 shares through a third-party allotment with a payment date of 23 March 2023, conducted in connection with the third-party allotment related to the over-allotment offering.」

    Following the listing and public offering described in the FY2022 report, payment for the 145,000-share third-party allotment was completed on 23 March 2023. The Company's post-listing capital strengthening has progressed in concrete terms.
  3. FY2022First statedAnnual report

    「The Company listed its shares on the Tokyo Stock Exchange Standard Market on 22 February 2023. In connection with the listing, the Board of Directors resolved at its meetings held on 19 January 2023 and 2 February 2023 to issue new shares through a public offering as follows, and payment was completed on 21 February 2023.」

    The Company conducted a public offering of 464,000 shares with total offering proceeds of ¥644.960 million and a third-party allotment of 145,000 shares. The proceeds were planned to be allocated to product development, personnel, advertising and promotion, and repayment of borrowings, among other purposes.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Gmo Prime Strategy yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stock Listings and Raising Growth Capital through Public Offerings and Third-Party Allotments | GMO PRIME STRATEGY CO.,LTD. (5250) | Komori